Option Care director sells 30,287 shares
Option Care Health director Pate R. Carter reported an open-market sale of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 30,287 | $32.0474 | $971K |
Footnotes (1)
- F1. Reflects the weighted average price of 30,287 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 27, 2026 with sale prices ranging from $32.00 to $32.275 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Pate R. Carter report for OPCH?
What does the Form 4 sale by Pate R. Carter indicate for OPCH investors?
Was Pate R. Carter’s OPCH stock sale executed in a single trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.